The many faces of estrogen signaling

Biochemia Medica

Volumn 24, Issue 3, 2014, Pages 329-342

  Vrtačnik, Peter ^a   Ostanek, Barbara ^a   Mencej Bedrač, Simona ^a   Marc, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

DNA methylation; Epigenetic mechanisms; Estrogen signaling; Extragonadal synthesis; miRNA

Indexed keywords

ADENYLATE CYCLASE; ANDROSTANOLONE; ANDROSTENEDIONE; CCAAT ENHANCER BINDING PROTEIN BETA; CHOLINE ACETYLTRANSFERASE; COLLAGENASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; GABA TRANSPORTER 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; PRASTERONE; PROTEIN C JUN; PROTEIN KINASE; PROTEIN KINASE C; REGULATOR PROTEIN; SOMATOMEDIN C; STAT5 PROTEIN; TESTOSTERONE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; ESTROGEN RECEPTOR;

BINDING AFFINITY; DIRECT GENOMIC SIGNALING; DNA METHYLATION; DNA RESPONSIVE ELEMENT; ENDOCRINE FUNCTION; EPIGENETICS; ESTROGEN ACTIVITY; ESTROGEN SIGNALING; ESTROGEN SYNTHESIS; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; INDIRECT GENOMIC SIGNALING; LIGAND INDEPENDENT SIGNALING; NON GENOMIC SIGNALING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; CHEMISTRY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; MALE; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

EPIGENESIS, GENETIC; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 84908125846     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/BM.2014.035     Document Type: Review

References (98)

1. Hall JE. Guyton and Hall textbook of medical physiology. 12th ed. Philadelphia, PA: Saunders/Elsevier, 2011.
2. Nilsson S, Gustafsson J. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011;89:44-55.http://dx.doi.org/10.1038/clpt.2010.226.
3. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris) 2003;64:95-107.
4. Venken K, Boonen S, Bouillon R, Vanderschueren D. Chapter 24. Gonadal Steroids. In: Rosen CJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Washington: ASBMR; 2009. p. 117-23.
5. Gallou-Kabani C, Vige A, Gross MS, Junien C. Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007;45:321-7.http://dx.doi.org/10.1515/CCLM.2007.081.
6. Kuhlmann JD, Rasch J, Wimberger P, Kasimir-Bauer S. microRNA and the pathogenesis of ovarian cancer - a new horizon for molecular diagnostics and treatment? Clin Chem Lab Med 2012;50:601-15.
7. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-30.http://dx.doi. org/10.1016/S0960-0760(03)00360-1.
8. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J. Concentration of sex steroids in adipose tissue after menopause. Steroids 1998;63:319-21.http://dx.doi.org/10.1016/S0039-128X(98)00019-1.
9. Blankenstein MA, van de Ven J, Maitimu-Smeele I, Donker GH, de Jong PC, Daroszewski J, et al. Intratumoral levels of estrogens in breast cancer. J Steroid Biochem Mol Biol 1999;69:293-7.http://dx.doi.org/10.1016/S0960-0760- (99)00048-5.
10. Mady EA, Ramadan EE, Ossman AA. Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients. Dis Markers 2000;16:151-7.http://dx.doi.org/10.1155/2000/305940.
11. Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113-8.http://dx.doi.org/10.1016/0303-7207(91)90116-A.
12. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535-65.
13. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007;87:905-31.http:// dx.doi.org/10.1152/physrev.00026.2006.
14. Ajj H, Chesnel A, Pinel S, Plenat F, Flament S, Dumond H. An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. PLoS One 2013;8:e61758.http://dx.doi.org/10.1371/journal.pone. 0061758.
15. Filardo EJ, Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 2012;153:2953-62.http://dx.doi. org/10.1210/en.2012-1061.
16. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, et al. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007;148:3236-45.http://dx.doi.org/10.1210/en.2006- 1605.
17. Sanden C, Broselid S, Cornmark L, Andersson K, Daszkiewicz- Nilsson J, Martensson UE, et al. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol Pharmacol 2011;79:400-10.http://dx.doi.org/10.1124/mol.110.069500.
18. Lodish H, Berk A, Kaiser CA, Krieger M, Scott MP, Bretscher A, et al. Molecular cell biology. 6th ed. New York: W.H. Freeman and Company; 2008.
19. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005;19:833-42.http://dx.doi.org/10.1210/me.2004-0486.
20. Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity (Edinb) 2010;105:4-13.http://dx.doi.org/10.1038/ hdy.2010.54.
21. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28:1057-68.http://dx.doi. org/10.1038/nbt.1685.
22. Klinge CM. miRNAs and estrogen action. Trends Endocrinol Metab 2012;23:223-33.http://dx.doi.org/10.1016/j. tem.2012.03.002.
23. Mann M, Cortez V, Vadlamudi RK. Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy. Cancers (Basel) 2011;3:1691-707.http://dx.doi.org/10.3390/cancers3021691.
24. Bulynko YA, O'Malley BW. Nuclear receptor coactivators: structural and functional biochemistry. Biochemistry 2011;50:313-28.http://dx.doi.org/10.1021/bi101762x.
25. Kawai H, Li H, Avraham S, Jiang S, Avraham HK. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 2003;107:353-8.http://dx.doi.org/10.1002/ijc.11403.
26. Macaluso M, Cinti C, Russo G, Russo A, Giordano A. pRb2/ p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130- E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene 2003;22:3511-7.http:// dx.doi.org/10.1038/sj.onc.1206578.
27. Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. Clin Cancer Res 2009;15:3672-9.http://dx.doi.org/10.1158/1078-0432. CCR-08-2343.
28. Hostetter CL, Licata LA, Keen JC. Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. Cancer Lett 2009;275:178-84.http://dx.doi.org/10.1016/j.canlet.2008.10.005.
29. Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, et al. SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer. Cancer Res 2011;71:6654-64.http://dx.doi. org/10.1158/0008-5472.CAN-11-1446.
30. Yao Y, Li H, Gu Y, Davidson NE, Zhou Q. Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling. Carcinogenesis 2010;31:382-7.http://dx.doi.org/10.1093/carcin/ bgp308.
31. Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, et al. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 2004;64:8184-92.http://dx.doi.org/10.1158/0008-5472. CAN-04-2045.
32. Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 2008;68:210-22.http://dx.doi.org/10.1002/pros.20673.
33. Yap OW, Bhat G, Liu L, Tollefsbol TO. Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. Anticancer Res 2009;29:139-44.
34. Tu Z, Li H, Ma Y, Tang B, Tian J, Akers W, et al. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression. Mol Cell Biochem 2012;366:111-22.http://dx.doi.org/10.1007/s11010- 012-1288-9.
35. Pitta CA, Papageorgis P, Charalambous C, Constantinou AI. Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. Cancer Lett 2013;337:167-76.http://dx.doi.org/10.1016/j. canlet.2013.05.031.
36. Stolzenberg DS, Stevens JS, Rissman EF. Experience-facilitated improvements in pup retrieval; evidence for an epigenetic effect. Horm Behav 2012;62:128-35.http://dx.doi.org/10.1016/j.yhbeh.2012.05.012.
37. Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor- alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007;21:1132-47.http://dx.doi.org/10.1210/ me.2007-0022.
38. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, et al. MicroRNA- 221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008;283:31079-86.http://dx.doi.org/10.1074/ jbc.M806041200.
39. Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, et al. MicroRNA- 18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009;136:683-93.http://dx.doi. org/10.1053/j.gastro.2008.10.029.
40. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009;28:3926-36.http://dx.doi.org/10.1038/onc.2009.241.
41. Pandey DP, Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009;29:3783-90.http://dx.doi.org/10.1128/ MCB.01875-08.
42. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A 2009;106:15732-7.http://dx.doi.org/10.1073/pnas.0906947106.
43. Loven J, Zinin N, Wahlstrom T, Muller I, Brodin P, Fredlund E, et al. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A 2010;107:1553-8.http://dx.doi.org/10.1073/ pnas.0913517107.
44. Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker RR, et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat 2011;127:69-80.http://dx.doi. org/10.1007/s10549-010-0972-2.
45. Tang L, Pu Y, Wong DK, Liu T, Tang H, Xiang T, et al. The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai) 2011;43:640-6.http://dx.doi.org/10.1093/ abbs/gmr051.
46. Al-Nakhle H, Burns PA, Cummings M, Hanby AM, Hughes TA, Satheesha S, et al. Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. Cancer Res 2010;70:4778-84.http://dx.doi.org/10.1158/0008-5472. CAN-09-4104.
47. Issa JP, Zehnbauer BA, Civin CI, Collector MI, Sharkis SJ, Davidson NE, et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996;56:973-77.
48. Sasaki M, Kotcherguina L, Dharia A, Fujimoto S, Dahiya R. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer. Cancer Res 2001;61:3262-6.
49. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto S, et al. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 2002;94:384-90.http://dx.doi.org/10.1093/jnci/94.5.384.
50. Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, et al. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene 2003;22:7600-6.http://dx.doi.org/10.1038/sj.onc.1207100.
51. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, et al. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 2004;164:2003-12.http://dx.doi. org/10.1016/S0002-9440(10)63760-1.
52. Suzuki F, Akahira J, Miura I, Suzuki T, Ito K, Hayashi S, et al. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. Cancer Sci 2008;99:2365-72.http://dx.doi.org/10.1111/ j.1349-7006.2008.00988.x.
53. Wei J, Han B, Mao XY, Wei MJ, Yao F, Jin F. Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients. Tumour Biol 2012;33:413-20.http://dx.doi.org/10.1007/s13277-011-0234-x.
54. Cohen A, Shmoish M, Levi L, Cheruti U, Levavi-Sivan B, Lubzens E. Alterations in micro-ribonucleic acid expression profiles reveal a novel pathway for estrogen regulation. Endocrinology 2008;149:1687-96.http://dx.doi.org/10.1210/ en.2007-0969.
55. Elbaz A, Rivas D, Duque G. Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice. Biogerontology 2009;10:747-55.http://dx.doi.org/10.1007/s10522-009-9221-7.
56. Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, et al. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor- positive breast cancer. Oncogene 2005;24:4531-9.http://dx.doi.org/10.1038/sj.onc.1208646.
57. Denger S, Bahr-Ivacevic T, Brand H, Reid G, Blake J, Seifert M, et al. Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblastspecific regulation of the insulin-like growth factor binding protein 4 gene. Mol Endocrinol 2008;22:361-79.http:// dx.doi.org/10.1210/me.2007-0292.
58. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 2009;37:2584-95.http://dx.doi.org/10.1093/nar/gkp117.
59. Zhang Y, Eades G, Yao Y, Li Q, Zhou Q. Estrogen receptor α signaling regulates breast tumor-initiating cells by downregulating miR-140 which targets the transcription factor SOX 2. J Biol Chem 2012;287:41514-22.http://dx.doi.org/10.1074/jbc.M112.404871.
60. Zhao J, Imbrie GA, Baur WE, Iyer LK, Aronovitz MJ, Kershaw TB, et al. Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2013;33:257-65.http://dx.doi.org/10.1161/ATVBAHA.112.300200.
61. Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, et al. A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Hum Mol Genet 2014;23:355-67.http://dx.doi.org/10.1093/hmg/ddt426.
62. Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, et al. Estrogen mediated-activation of miR- 191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet 2013;9:e1003311.http://dx.doi.org/10.1371/journal. pgen.1003311.
63. Maillot G, Lacroix-Triki M, Pierredon S, Gratadou L, Schmidt S, Benes V, et al. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res 2009;69:8332-40.http://dx.doi.org/10.1158/0008- 5472.CAN-09-2206.
64. Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, et al. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 2012;31:4196-206.http://dx.doi.org/10.1038/onc.2011.583.
65. Edvardsson K, Nguyen-Vu T, Kalasekar SM, Ponten F, Gustafsson J, Williams C. Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells. Carcinogenesis 2013;34:1431-41.http://dx.doi. org/10.1093/carcin/bgt067.
66. Jacovetti C, Abderrahmani A, Parnaud G, Jonas JC, Peyot ML, Cornu M, et al. MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity. J Clin Invest 2012;122:3541-51.http://dx.doi.org/10.1172/JCI64151.
67. Zhai R, Wang G, Cai K, Tao K, Xu F, Zhang W, et al. Epigenetic regulation of the ERbeta gene on the estrogen signal transfection pathway in colon cancer cells. J Huazhong Univ Sci Technolog Med Sci 2010;30:69-74.http://dx.doi.org/10.1007/s11596-010-0112-6.
68. Kubarek Ł, Jagodzinski PP. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells. FEBS Lett 2007;581:1441-8.http://dx.doi. org/10.1016/j.febslet.2007.02.070.
69. Cui M, Wen Z, Yang Z, Chen J, Wang F. Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells. Mol Biol Rep 2009;36:2201-7.http://dx.doi.org/10.1007/s11033-008-9435-9.
70. Yamagata Y, Asada H, Tamura I, Lee L, Maekawa R, Taniguchi K, et al. DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum Reprod 2009;24:1126-32.http://dx.doi.org/10.1093/humrep/dep015.
71. Logan PC, Ponnampalam AP, Steiner M, Mitchell MD. Effect of cyclic AMP and estrogen/progesterone on the transcription of DNA methyltransferases during the decidualization of human endometrial stromal cells. Mol Hum Reprod 2013;19:302-12.http://dx.doi.org/10.1093/molehr/gas062.
72. Chao HH, Zhang XF, Chen B, Pan B, Zhang LJ, Li L, et al. Bisphenol A exposure modifies methylation of imprinted genes in mouse oocytes via the estrogen receptor signaling pathway. Histochem Cell Biol 2012;137:249-59.http://dx.doi.org/10.1007/s00418-011-0894-z.
73. Marques M, Laflamme L, Gaudreau L. Estrogen receptor α can selectively repress dioxin receptor-mediated gene expression by targeting DNA methylation. Nucleic Acids Res 2013;41:8094-106.http://dx.doi.org/10.1093/nar/gkt595.
74. Cheng AS, Culhane AC, Chan MW, Venkataramu CR, Ehrich M, Nasir A, et al. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res 2008;68:1786-96.http://dx.doi.org/10.1158/0008- 5472.CAN-07-5547.
75. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006;66:5624-32.http://dx.doi.org/10.1158/0008-5472. CAN-06-0516.
76. Thomas L, ed. Clinical laboratory diagnostics: Use and assessment of clinical laboratory results. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft mbH.; 1998.
77. Olde B, Leeb-Lundberg LM. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 2009;20:409-16.http://dx.doi.org/10.1016/j.tem.2009.04.006.
78. Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, Ravo M, et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 2010;176:2113-30.http://dx.doi.org/10.2353/ ajpath.2010.090837.
79. Ferraro L, Ravo M, Nassa G, Tarallo R, De Filippo MR, Giurato G, et al. Effects of oestrogen on microRNA expression in hormone-responsive breast cancer cells. Horm Cancer 2012;3:65-78.http://dx.doi.org/10.1007/s12672-012-0102-1.
80. Pinho FG, Frampton AE, Nunes J, Krell J, Alshaker H, Jacob J, et al. Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Res 2013;73:5936-48.http://dx.doi.org/10.1158/0008-5472.CAN-13-0158.
81. Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, et al. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res 2011;13:R116.http://dx.doi.org/10.1186/bcr3059.
82. Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D. Induction of cell proliferation and survival genes by estradiol- repressed microRNAs in breast cancer cells. BMC Cancer 2012;12:29.http://dx.doi.org/10.1186/1471-2407-12-29.
83. Yamagata K, Fujiyama S, Ito S, Ueda T, Murata T, Naitou M, et al. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol Cell 2009;36:340-7.http://dx.doi. org/10.1016/j.molcel.2009.08.017.
84. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, et al. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 2010;102:706-21.http://dx.doi.org/10.1093/jnci/ djq102.
85. Qian P, Zuo Z, Wu Z, Meng X, Li G, Zhang W, et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 2011;71:6463-74.http://dx.doi. org/10.1158/0008-5472.CAN-11-1322.
86. Kim K, Madak-Erdogan Z, Ventrella R, Katzenellenbogen BS. A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-alpha and ERK2 that controls breast cancer proliferation and invasiveness properties. Horm Cancer 2013;4:78-91.http://dx.doi.org/10.1007/s12672-012-0129-3.
87. Nagpal N, Ahmad HM, Molparia B, Kulshreshtha R. MicroRNA- 191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 2013;34:1889-99.http://dx.doi.org/10.1093/carcin/ bgt107.
88. He YQ, Sheng JQ, Ling XL, Fu L, Jin P, Yen L, et al. Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-beta in colorectal cells. Exp Mol Med 2012;44:723-32.http://dx.doi.org/10.3858/ emm.2012.44.12.079.
89. Queiros AM, Eschen C, Fliegner D, Kararigas G, Dworatzek E, Westphal C, et al. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol 2013;169:331-8.http://dx.doi.org/10.1016/j.ijcard.2013.09.002.
90. Nothnick WB, Healy C. Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod Sci 2010;17:987-94.http://dx.doi.org/10.1177/1933719110377472.
91. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008;112:4591-7.http://dx.doi.org/10.1182/blood- 2008-04-152488.
92. Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, et al. Estrogen regulates the tumour suppressor miRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One 2014;9:e90810.http://dx.doi.org/10.1371/journal.pone.0090810.
93. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 2009;37:4850-61.http://dx.doi.org/10.1093/nar/ gkp500.
94. Masuda M, Miki Y, Hata S, Takagi K, Sakurai M, Ono K, et al. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma. J Transl Med 2012;10:S2.http:// dx.doi.org/10.1186/1479-5876-10-S1-S2.
95. Zhang C, Zhao J, Deng H. 17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol Cell Biochem 2013;379:201-11.http://dx.doi.org/10.1007/s11010-013-1642-6.
96. Wang G, Wang Y, Shen C, Huang YW, Huang K, Huang TH, et al. RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation. PLoS One 2010;5:e13798.http://dx.doi.org/10.1371/journal.pone. 0013798.
97. Zhang R, He Y, Zhang X, Xing B, Sheng Y, Lu H, et al. Estrogen receptor-regulated microRNAs contribute to the BCL2/ BAX imbalance in endometrial adenocarcinoma and precancerous lesions. Cancer Lett 2012;314:155-65.http://dx.doi.org/10.1016/j.canlet.2011.09.027.
98. Cochrane DR, Cittelly DM, Howe EN, Spoelstra NS, McKinsey EL, LaPara K, et al. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. Horm Cancer 2010;1:306-19.http://dx.doi.org/10.1007/s12672-010- 0043-5.